Skip to main content

From wild relatives to super tomatoes

From wild relatives to super tomatoes: Unearthing new genetic potential



Tomato breeding has historically depended on a narrow genetic pool, leading to decreased diversity and loss of valuable traits. Traditional methods and biparental populations fall short in harnessing the full potential of wild relatives, posing challenges in improving traits like fruit size, disease resistance, and adaptability. Addressing these challenges, comprehensive genetic resources that integrate diverse alleles from wild and weedy tomatoes are essential for discovering novel genes and boosting breeding efficiency.

In collaboration with ENEA, researchers from the Universitat Politècnica de València developed an eight-way tomato Multiparental advanced generation intercross (MAGIC) population combining Solanum lycopersicum var. cerasiforme and Solanum pimpinellifolium.

Published in Horticulture Research on June 3, 2024, the study highlights how this population aids in identifying genes associated with key traits. By intercrossing eight founders with diverse genetic backgrounds, the team created 354 genotyped lines, bridging the gap between wild and cultivated tomatoes and providing breeders with a powerful tool for crop improvement.

The tomato MAGIC (ToMAGIC) population comprises 354 lines derived from eight diverse founder lines of wild and weedy tomatoes, revealing 6,488 high-quality SNPs. Phenotyping identified associations with traits such as fruit size, leaf morphology, and pigmentation.

Notably, the WUSCHEL gene was linked to locule number, a crucial trait in domestication, while the FW2.2 gene was associated with fruit weight. Dominant wild alleles offer potential for enhancing cultivated varieties. A novel mutation in the SlMYB-ATV gene was also discovered, influencing anthocyanin production, particularly in cold-adapted founders. These findings underscore ToMAGIC's role in uncovering genetic variations crucial for developing resilient, productive tomatoes.

"The ToMAGIC population marks a major advancement in tomato genetics," stated Dr. Santiago Vilanova, the study's senior researcher from the Universitat Politècnica de València. "By incorporating wild and weedy relatives, we've created a resource that not only taps into uncharted genetic diversity but also enhances our ability to discover and validate genes. This breakthrough enables us to overcome genetic limitations and develop superior tomato cultivars with enhanced traits."

The ToMAGIC population holds significant potential for tomato breeding, offering a pathway to integrate wild genetic diversity into breeding programs. It helps identify novel genes governing key traits, enabling the creation of resilient, high-yielding tomato varieties. Beyond research, ToMAGIC can directly impact the selection of elite lines for commercial breeding, enhancing crop performance across varying environments and meeting the rising demand for better agricultural productivity.

innovation, growth, success, opportunity, development, progress, strategy, performance, leadership, vision, talent, capability, expansion, achievement, ambition, potential, impact, scalability, resilience, excellence,

International Conference on Genetics and Genomics of Diseases 




For Enquiries: genetics@healthcarek.com 

Get Connected Here 
--------------------------------- 
--------------------------------- 
facebook.com/profile.php?id=61555903296992 
tumblr.com/blog/dorita0211 

Comments

Popular posts from this blog

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...

Post-Stroke Cardiovascular risks

Study finds genetic factors key to post-stroke cardiovascular risks In a recent study published in the journal Stroke , researchers identify genetic and molecular risk factors for subsequent cardiovascular outcomes after incident stroke in an effort to identify potential therapeutic targets to improve patient prognoses. Identifying the causes of stroke Stroke is a major global health issue that causes significant disability and mortality, particularly arterial ischemic stroke (AIS). AIS, which is a type of stroke caused by blocked blood flow to the brain, is responsible for up to 85% of stroke cases. AIS arises due to cerebral blood vessel blockage, with modifiable risk factors including hypertension, diabetes, dyslipidemia, atrial fibrillation, obesity, and lifestyle behaviors. Although genome-wide association studies (GWAS) often focus on incident strokes, studying subsequent events can provide new insights into stroke progression. Further research is crucial to identify genetic and...

Type of Inherited Blindness in Dogs

Genetic test could eradicate a type of inherited blindness in dogs A mountain rescue dog whose duties ended after her eyesight failed has helped scientists create a test that could eradicate the genetic eye condition in her breed for good. Shola the English shepherd has an inherited eye disease called progressive retinal atrophy (PRA) that causes the light-sensitive cells at the back of the eye to deteriorate, eventually leading to blindness. PRA affects more than 100 dog breeds, can be caused by a number of different genetic variants and has no treatment. For some types, symptoms do not appear until the dog is several years old , by which point they may have passed their genes on to puppies. Katherine Stanbury, the first author of the research from the University of Cambridge, said Shola was four years old when she began struggling with her vision in dim light. “She was sent to a veterinary ophthalmologist and they confirmed that she had PRA,” said Stanbury. “And then it turned out h...